title: EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.
authors.affiliation: Department of Internal Medicine, University of Cologne, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Engert
authors.forename: Rauol
authors.initials: R
authors.lastname: Herbrecht
authors.forename: Armando
authors.initials: A
authors.lastname: Santoro
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Zinzani
authors.forename: Igor
authors.initials: I
authors.lastname: Gorbatchevsky
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000009:adverse effects; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012061:Relapsing Fever
chemical_list: D000970:Antineoplastic Agents; D007546:Isoquinolines; C086548:pixantrone